Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Spinout deals fall 33% as seed dries up

2 min read
16:30UTC

University spinout equity deals fell 33% by count and 51% by value in 2025, extending a pipeline already skewed to sub-£500,000 rounds.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

University spinout funding is drying up, thinning the pipeline of scale-ups Britain will have in 2027.

University spinout equity deals fell 33% by count and 51% by value in 2025, the sharpest contraction in the commercialisation pipeline this cycle, the British Business Bank tracker showed⁠1. It extends a figure already on the record: 36.7% of 2025 spinout rounds closed below £500,000.

Universities carve spinouts out of their research to commercialise it. Fewer seed-stage spinouts now means a shallower Series A pipeline in 2027, since the funding stages feed one another; capital that might have scaled university science will chase other sectors instead.

The retail money that once seeded these companies has thinned. His Majesty's Revenue and Customs (HMRC) counted 33,220 investors using the Enterprise Investment Scheme (EIS), a tax relief for angels backing young firms, down 7%, before April's cut to Venture Capital Trust (VCT) relief compounded the fall. Private managers are rebuilding the tier by hand: Seedcamp closed a $320m fund, the Bank cornerstoned Longwall Ventures for sub-£2m cheques, and Lansdowne Partners anchored a university-IP fund. Each is selective, none is an open programme, so the recovery reaches some founders and not others.

Deep Analysis

In plain English

University spinouts are companies created to commercialise research done inside a university, such as a new drug or piece of hardware. In 2025 the number of spinout equity deals fell 33% and the total money raised fell 51%, with more than a third of all spinout rounds closing below £500,000, a very small amount for a company trying to build a product from a lab discovery. Much of the money that used to back these small, risky early rounds came from individual investors using tax reliefs called EIS and VCT. Government figures already showed 7% fewer people claiming that relief before ministers cut it further in April 2026, drying up one of the few funding taps spinouts could rely on.

Deep Analysis
Root Causes

Two separate mechanisms compound rather than one single cause. HMRC data already showed a 7% fall in EIS-claiming investors before this April's Venture Capital Trust relief cut took effect, meaning the retail angel base was thinning independently of the policy change.

The April 2026 VCT relief cut then removed a second, larger pool of retail capital that specifically fills reserve rounds below £2m, the exact size band where 36.7% of 2025 spinout rounds closed. Losing both pools within eighteen months hit the smallest deals hardest, because they have no alternative source of patient, tax-advantaged capital at that size.

What could happen next?
  • Consequence

    Fewer sub-£2m spinout rounds closing means fewer early-stage discoveries reach commercialisation at all, regardless of their eventual quality.

Sources:British Business Bank
Mentions:British Business Bank →Small Business Equity Tracker →HMRC →Seedcamp →Longwall Ventures →Lansdowne Partners →Venture Capital Trusts →Enterprise Investment Scheme →Germany →
First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

British Business Bank· 4 Jul 2026
Read original →
Causes and effects
Caused by
EIS tax-relief claimants fell 7%
The 7% fall in EIS angel investors is a direct driver of the shrinking spinout equity tier.
Occurred 1 May 2026
Read story →
Midlands fund writes its first cheques
Midlands Mindforge's university-spinout fund is one of the private vehicles rebuilding the sub-GBP2m spinout tier the tracker shows contracting.
Occurred 10 Jun 2026
Read story →
Seedcamp closes its record $320m fund
Seedcamp's $320m fund close is part of the private-manager rebuild of the seed and spinout tier.
Occurred 22 Jun 2026
Read story →
State £50m backs the tier funds skip
The British Business Bank's Longwall Ventures cornerstone backstops the sub-GBP2m tier the tracker shows contracting.
Occurred 27 May 2026
Read story →
Lansdowne hits €128.9m on BBB-anchored fund
Lansdowne Partners' university-IP fund is part of the private capital rebuilding the spinout tier.
Occurred 14 May 2026
Read story →
UKRI confirms 58% cut to STFC labs
Connects to the tracker's 33% fall in spinout deal count, the same base STFC cuts thin further.
Occurred 9 Jul 2026
Read story →
This Event
Spinout deals fall 33% as seed dries up
A thinner spinout tier now feeds directly into a shallower Series A pipeline in 2027, independent of how much growth capital exists.
Led to
Risk Ledger raises £24m, no state money
Risk Ledger's ordinary Series B illustrates the private-capital-only pattern the Bank's own tracker showed contracting at seed and spinout stage.
Occurred 15 Jul 2026
Read story →
Moa raises £22.2m to outrun resistance
The 33% fall in spinout deal count is the declining pipeline Moa Technology's Series C closes against.
Occurred 23 Jul 2026
Read story →
Loughborough builds its own alumni pipe
Spinout deals falling 33% by count last year is the gap Loughborough's alumni investor network is built to address.
Occurred 24 Aug 2026
Read story →
C4X banks $13m as AstraZeneca doses
C4X's milestone cash arrives even as university spinout deal counts fell 33% and the listing route narrowed to New York.
Occurred 4 Sept 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.